2011 February 17 | Ergün Sahin1,2, Simona Colla1,2, Marc Liesa3,*, Javid Moslehi2,4, Florian L. Müller1,2, Mira Guo5, Marcus Cooper6, Darrell Kotton3, Attila J. Fabian7, Carl Walkey8, Richard S. Maser1,2, Giovanni Tonon1,2, Friedrich Foerster1,2, Robert Xiong1, Y. Alan Wang1, Sachet A. Shukla1, Mariela Jaskelioff1,2, Eric S. Martin1,2, Timothy P. Heffernan1, Alexei Protopopov1, Elena Ivanova1, John E. Mahoney1, Maria Kost-Alimova1, Samuel R. Perry1, Roderick Bronson9, Ronglih Liao4, Richard Mulligan7, Orian S. Shirihai3, Lynda Chin1,2, and Ronald A. DePinho1,2,4,7
Telomere dysfunction, which leads to p53-mediated cellular growth arrest, senescence, and apoptosis, is associated with progressive atrophy and functional decline in high-turnover tissues. However, its broader adverse impact across many tissues, including quiescent systems, has not been fully understood. Transcriptomic network analyses revealed that telomere dysfunction represses the peroxisome proliferator-activated receptor gamma, coactivator 1 alpha and beta (PGC-1α and PGC-1β) and their downstream network in mice lacking either telomerase reverse transcriptase or telomerase RNA component genes. This repression is linked to impaired mitochondrial biogenesis and function, decreased gluconeogenesis, cardiomyopathy, and increased reactive oxygen species (ROS). In telomere dysfunctional mice, enforced *Tert* or *PGC-1α* expression, or germline deletion of *p53* substantially restores PGC network expression, mitochondrial respiration, cardiac function, and gluconeogenesis. The study demonstrates that telomere dysfunction activates p53, which binds and represses *PGC-1α* and *PGC-1β* promoters, forming a direct link between telomere and mitochondrial biology. This telomere-p53-PGC axis is proposed to contribute to organ and metabolic failure and diminishing organismal fitness in the context of telomere dysfunction.Telomere dysfunction, which leads to p53-mediated cellular growth arrest, senescence, and apoptosis, is associated with progressive atrophy and functional decline in high-turnover tissues. However, its broader adverse impact across many tissues, including quiescent systems, has not been fully understood. Transcriptomic network analyses revealed that telomere dysfunction represses the peroxisome proliferator-activated receptor gamma, coactivator 1 alpha and beta (PGC-1α and PGC-1β) and their downstream network in mice lacking either telomerase reverse transcriptase or telomerase RNA component genes. This repression is linked to impaired mitochondrial biogenesis and function, decreased gluconeogenesis, cardiomyopathy, and increased reactive oxygen species (ROS). In telomere dysfunctional mice, enforced *Tert* or *PGC-1α* expression, or germline deletion of *p53* substantially restores PGC network expression, mitochondrial respiration, cardiac function, and gluconeogenesis. The study demonstrates that telomere dysfunction activates p53, which binds and represses *PGC-1α* and *PGC-1β* promoters, forming a direct link between telomere and mitochondrial biology. This telomere-p53-PGC axis is proposed to contribute to organ and metabolic failure and diminishing organismal fitness in the context of telomere dysfunction.